Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galena Biopharma Inc (NASDAQ:GALE)

0.315
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.26
Today|||52-Week Range
3.60
-83.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.5M9.3M0.000.00
 
 
 
Cost of Goods Sold199.0K954.0K0.000.00
 
 
 
Depreciation And Amortization452.0K889.0K355.0K142.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.8M7.5M-355.0K-142.0K
 
 
 
 
 
General Expenses35.7M57.7M33.9M31.7M
 
 
 
 
 
Research And Development21.1M28.4M23.6M19.9M
 
 
 
 
 
Total Operating Expenses36.3M59.5M34.2M31.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.8M-50.2M-34.2M-31.9M
 
 
 
 
 
Extraordinary Credit--16.7M1.7M27.3M
 
 
 
 
Extraordinary Charge-44.9M-2.0M-5.3M-2.8M
 
 
 
 
 
Interest Expense On Debt807.0K1.1M760.0K3.5M
 
 
 
 
 
Other Expenses3.9M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-75.6M-36.6M-38.6M-10.9M
 
 
 
 
 
Income Taxes-1.1M0.00-365.0K-243.0K
 
 
 
 
Discontinued Operations0.000.00-20.4M-12.4M
 
 
 
Extraordinary Items0.000.00-4.5M0.00
 
 
Net Income-76.7M-36.6M-59.4M-23.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.5M6.0M7.8M10.0M
 
 
 
 
 
Shares To Calculate EPS Diluted4.5M6.0M7.8M10.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$17.00-$6.20-$8.20-$2.36
 
 
 
 
 
EPS Diluted-$17.00-$6.20-$7.65-$2.36